There is a "fairly high" probability of seeing approved by September, at EU level, the first anti-Covid vaccine adapted to variants.

This was stated by the head of the EMA vaccine task force, Marco Cavaleri, during a press conference with journalists.

"It is not a mystery", added Caaleri "that those further ahead at the moment are the mRna vaccines ".

In this way, therefore, we could start with the new vaccination campaign against the coronavirus in the autumn.

Currently, EMA has also begun examining Moderna 's application for authorization to extend the use of its anti-Covid vaccine, Spikevax, to children between the ages of 6 months and 5 years . "We have just started the evaluation of the Moderna application, it is the first for this age group," said Cavaleri.

(Unioneonline / vl)

© Riproduzione riservata